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Introduction
Palliative care is an approach that improves the quality of 
life of patients and their families who are facing problems 
associated with life-threatening illness. Palliative care pre-
vents and relieves suffering through the early identification, 
correct assessment, and treatment of pain and other prob-
lems, whether physical, psychosocial, or spiritual [1]. Moreo-
ver, early palliative care, when combined with usual oncolo-
gy care, led to the improvement of mood and longer survival 
of non-small-cell lung carcinoma patients [2]. Based on many 
randomized clinical trials, several guidelines recommend the 
initiation of palliative care in advanced cancer patients at the 
early stage of their disease trajectories and the integration of 
concurrent palliative care into disease-directed, life-prolong-
ing therapies [3-5].
To implement early referral to palliative care, there is a 
need to assess symptoms and identify the unmet needs of 
advanced cancer patients [6]. In addition, palliative care teams 
also need comprehensive assessments of patients’ needs to 
provide holistic care. The Sheffield Profile for Assessment 
and Referral for Care (SPARC) was developed over a 5-year 
period by the Academic Unit of Supportive Care at the Uni-
versity of Sheffield. The SPARC is a holistic multidimensional 
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Purpose  This study aimed to validate the Sheffield Profile for Assessment and Referral to Care (SPARC) as an effective tool for screen-
ing palliative care needs among Korean cancer patients.    
Materials and Methods  The English version of the SPARC was translated by four Korean oncologists and reconciled by a Korean 
language specialist and a medical oncologist fluent in English. After the first version of the Korean SPARC (K-SPARC) was developed, 
back-translation into English was performed by a professional translator and bilingual oncologist. The back-translated version was 
reviewed by the original author (S.H.A.), and modifications were made (ver. 2). The second version of the K-SPARC was tested against 
other questionnaires, including the Functional Assessment of Cancer Therapy-General (FACT-G) and the Edmonton Symptom Assess-
ment System (ESAS).
Results  Thirty patients were enrolled in the pilot trial. Fifteen were male, and the median age was 64.5 years. Six patients had an East-
ern Cooperative Oncology Group performance status of 2 or more. All patients except one were receiving chemotherapy. Regarding 
internal consistency, the Cronbach’s α scores for physical symptoms, psychological issues, religious and spiritual issues, independ-
ency and activity, family and social issues, and treatment issues were 0.812, 0.804, 0.589, 0.843, 0.754, and 0.822, respectively. 
The correlation coefficients between the SPARC and FACT-G were 0.479 (p=0.007) for the physical domain and –0.130 (p=0.493) 
for the social domain. 
Conclusion  This pilot study indicates that the K-SPARC could be a reliable tool to screen for palliative care needs among Korean 
cancer patients. A further study to validate our findings is ongoing.  
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screening questionnaire regarding supportive and palliative 
care needs regardless of the diagnosis. The SPARC is a self-
rated questionnaire with a total of 45 questions under the 
following eight subscales: communication and information 
issues, physical symptoms, psychological issues, religious 
and spiritual issues, independence and activity, family and 
social issues, treatment issues, and personal issues. The 
SPARC helps healthcare professionals to identify patients and 
families that would benefit from a referral to specialist sup-
portive and palliative care [7]; it was translated into Polish 
and then validated by Leppert et al. [8]. The aim of this study 
was to develop a Korean version of the SPARC (K-SPARC) 
and validate the K-SPARC for the evaluation of palliative care 
needs among Korean cancer patients. 
Materials and Methods
In this study, we translated and back-translated the SPARC 
and then conducted a pilot study of the K-SPARC by con-
ducting semistructured debriefing interviews. To evaluate 
the reliability of the K-SPARC, we measured the internal 
consistency by calculating the Cronbach’s alpha coefficients 
of six of the subscales. We evaluated the criterion valid-
ity through correlation analysis of the K-SPARC with other 
tools such as the physical well-being and social well-being 
domains of the Functional Assessment of Cancer Therapy-
General (FACT-G).
1. Translation and back-translation process
Ahmed et al. [7] provided approval for the translation of 
the SPARC into Korean. The translation and back-translation 
processes are detailed in Fig. 1. Four Korean oncologists flu-
ent in English (S.K.B., J.H.K., Y.J.K., M.A.L.) independently 
translated the 45 items of SPARC, including the response 
options and questionnaire instructions. The expert panel 
which was consisted of five oncologists including four pri-
mary translators reviewed each translation and reconciled 
the translations to create the first version of the K-SPARC. 
The first version of the K-SPARC was reviewed by a Korean 
language specialist (J.C.S.), and the items were modified to 
reflect the layperson’s perspective in the second version of 
the K-SPARC. The expert panel reviewed the second version 
of the K-SPARC, and a professional translator and a bilin-
gual oncologist back-translated it into English. This transla-
tion was reviewed by S.H.A. and was found to be consistent 
with the original English: a few minor discrepancies were 
discussed and allowed for linguistic or cultural differences 
and for variations in healthcare systems.
2. Pilot study
The pilot study was performed with the translated version 
of the SPARC (Supplementary Material), and two rounds of 
semistructured debriefing interviews were conducted with 
15 patients in each round. Patients were asked if the instruc-
tions were clear and easy to understand, if there were any 
word that were difficult to understand, if the order of items 
was appropriate, if the questionnaire was easy to complete, 
if they needed help completing the survey and if there were 
additional suggestions. The debriefing interviews were per-
formed by a palliative care nurse who had been trained for 
interviewing.
3. Patients
Patients who were 20 years old or older, who had advanced 
cancer and who understood written Korea were included. 
Patients with symptomatic brain metastasis, a psychologic 
condition that could not be controlled or that affected cog-
nition, or cognitive problems such as dementia or delirium 
were excluded. The following patient demographics were 
collected from the patient’s medical record upon enrollment: 
age, sex, Eastern Cooperative Oncology Group (ECOG) per-
formance status, diagnosis, stage of cancer, current cancer 
treatment, duration of disease, admission status, and edu-
cation level. Patients completed the initial questionnaires 
including the SPARC, Edmonton Symptom Assessment Sys-
tem (ESAS), and FACT-G, on the same day.
4. Instruments used in the study
The instruments used in this study were the Korean ver-
sion of the ESAS (K-ESAS), the Korean version of the FACT-
G (FACT-G Korean), and the ECOG performance status; 
these instruments were used as comparative tools, as well as 
to test the feasibility of survey set.  
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Fig. 1.  The translation and back-translation processes.
Reviewed by a Korean language specialist
and reconciliation
Forward translation by four oncologists
Backward translation (2 bilinguals)
Backward translation (2 bilinguals)
Reconciliation by expert panel
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 1) Sheffield Profile for Assessment and Referral for Care 
(SPARC)
The SPARC is a self-rated questionnaire to screen for sup-
portive and palliative care needs and contains a total of 45 
questions under in the following eight subscales: communi-
cation and information issues (1 question), physical symp-
toms (21 questions), psychological issues (9 questions), reli-
gious and spiritual issues (2 questions), independence and 
activity (3 questions), family and social issues (4 questions), 
treatment issues (2 questions), and personal issues (3 ques-
tions). Among the 45 items, four are yes/no questions, and 
the other items are scored on a four-point Linkert scale with 
the following options: not at all, a little bit, quite a bit, and 
very much. For the Polish version of the SPARC, the Cron-
bach’s alpha coefficients for physical symptoms, psychologi-
cal issues, religious and spiritual issues, independence and 
activity, and family and social issues were 0.68, 0.86, 0.65, 
0.77, 0.80, and 0.62, respectively [8].
 
 2) Other instruments to evaluate the quality of life of 
cancer patients
The instruments used in this study were the K-ESAS, the 
FACT-G Korean, and the ECOG performance status; these 
instruments were used as comparative tools, as well as to 
test the feasibility of the survey set. The ESAS uses numerical 
scales ranging from zero to 10 to assess the average inten-
sity (10 indicates highest intensity) of symptoms experienced 
during the previous 24 hours, namely, pain, fatigue, nausea, 
depression, anxiety, drowsiness, loss of appetite, decreased 
well-being, dyspnea, and sleep disturbance [9,10]; the K-ES-
AS has been validated [11].
The FACT-G scale, which was developed and validated 
by Cella et al. [12] in the United States, consists of a total of 
27 Likert-type items formulated into separate subscales, i.e., 
physical (seven items), emotional (six items), social/family 
(seven items) and functional (seven items) well-being; it is 
widely used to measure health-related quality of life in can-
cer patients [12]. The FACT-G has also been translated into 
Korean and validated [13].
Physical activity was evaluated by the ECOG performance 
status. The performance status is indicated on a scale from 
0-5 according to a chart of activities of daily life and is an 
indicator that is widely used by researchers and clinicians.
5. Statistical analysis
Descriptive statistics were used to summarize the data. The 
reliability of the K-SPARC was measured in this study based 
on the internal consistency of the SPARC using Cronbach’s 
alpha coefficients, and it will be assessed in a future study 
based on the test-retest reliability. The internal test-retest reli-
ability of the Cronbach’s alpha coefficients for 41 items under 
six factors will be evaluated with the correlation coefficients 
between the measured values at the beginning of the first sev-
en days and 3 days later. Cronbach’s alpha is the most com-
monly used measure of internal consistency. Internal consist-
ency is generally considered good if the coefficient is 0.60 or 
higher [14]. Validity was evaluated in terms of the construct 
validity and the criterion validity. The construct validity was 
evaluated for six areas (physical symptoms, psychological 
issues, religious and spiritual issues, independence and 
activity, family and social issues, and treatment issues) from 
the English version. We analyzed the factors of the K-SPARC 
by conducting a factor analysis of the translated Korean ver-
sion. A correlation analysis with the FACT-G, as the gold 
standard, was also conducted. Of the four factors of the FACT-
G (physical well-being, social/family well-being, emotional 
well-being, and functional well-being), correlation analysis 
of the physical well-being and social well-being dimensions 
with the SPARC was conducted. The statistical analysis was 
performed with the SPSS ver. 23.0 statistical software pack-
age (IBM Corp., Armonk, NY). A p-value less than 0.05 was 
considered significant in the statistical analysis.
Results
1. Modification of items based on cultural differences
In the translation and back-translation process, the modi-
fication of the items was not permitted except for changing 
“b. community nurse” and “c. hospital nurse” to “nurse” in 
the communication and information issues section because 
of the differences in the healthcare system between the UK 
and Korea. Several items also needed to be modified due to 
the constraints of the Korean language. It was difficult to find 
an appropriate translation for “sore mouth” in Korean. We 
decided to modify this phrase as “oral pain” (Gugang Tongje-
ung) in the physical symptoms section. The phrase “feeling 
as if you are in a low mood” was used in the original version 
to avoid making respondents feel negative or embarrassed; 
however, in Korean feeling depressed (WooUlham) is differ-
ent from depression (WooUljeung) itself, so we decided to 
use “WooUlham”. No patients expressed embarrassment or 
annoyance with the word “WooUlham”. The phrase “feeling 
that life is not worth living” was translated into “feeling that 
life is meaningless” because the expert panel decided that 
“not worth living” (Sal Ga Chiga Eopseum) seemed more 
aggressive than “meaningless” (Saneun Geosi Uimi Eopne-
un Geotgateum) and more related to suicide in Korean. The 
phrase “thoughts about ending it all” is a soft expression for 
suicide in the original version, and the expert panel had diffi-
culty determining a soft, metaphorical expression in Korean. 
We ultimately decided on “Modeun Geoseul Kkeutnaeya 
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getdaneun Saenggak”. Finally, we discussed the term “dis-
tress” in Korean at great length. There is no exact word for 
distress in Korean, and a previous validation of the Korean 
version of the Distress Thermometer used the English term 
itself [15]. We also decided to use the English term “distress” 
itself and included a description of the term as referring to 
total pain (Jeonbanjeokin Gotong) in parentheses next to it.
2. Two rounds of a pilot study of the SPARC survey
A total of 30 patients were included in the pilot trial 
between 10 December 2018 and 21 February 2019. In the 
first round of the study, 15 patients were enrolled. Only one 
patient expressed difficulties with several words, including 
urinary problems (Banggwang Munje), sex life (SeongSaeng-
hwal), sore mouth (Gugang Tongjeung), and feeling week 
(Soeyakgam), and the other patient expressed difficulty with 
the word “distress.” Others had no difficulties to understand 
each item. We conducted a second round with an additional 
15 patients. The pilot study was complete after the second 
round because patients no longer expressed difficulties in 
completing the survey. Of all the patient, 19 indicated that 
the difficulty level of the questions was easy and clear, and 
10 patients indicated a moderate difficulty level. Twenty-sev-
en patients agreed with the order of the questionnaire. The 
expert panel reviewed the questionnaire, and the response 
of one patient was concluded to be an outlier. Two patients 
expressed additional problems, including with information 
on patient advocacy, cancer rehabilitation, and new cancer 
drugs. The median time to respond to the survey, including 
the SPARC, FACT-G, and K-ESAS, was 20 minutes (Q1-Q3, 
20-35 minutes), and the median time to complete only the 
SPARC was 5 minutes (Q1-Q3, 10-15 minutes; minimum-
maximum, 5-25 minutes). The median difficulty score of the 
SPARC was 2 (on a Likert scale from 1, very easy, to 5, very 
difficult; Q1-Q3, 2-3).
Of the 30 patients in the study, 50% were men, and the 
mean age was 61.6 years (range, 52 to 69.3 years). Gastro-
intestinal tumors were the most common primary cancers, 
followed by head and neck cancers, breast cancer, and lym-
phoma/myeloma. Of all the patients, 80% had stage IV can-
cer, and 97% were receiving chemotherapy. The patients’ 
demographics are detailed in Table 1. The reliability of the 
Cancer Res Treat. 2021;53(1):25-31
Table 1.  Demographic characteristics of the patients
Characteristic No. (%)
Age, median (range, yr) 64.5 (52-69.3)
Sex  
    Male 15 (50)
    Female 15 (50)
Performance status
    0, 1 24 (80)
    2, 3 6 (20)
Diagnosis
    Gastrointestinal tumor 8 (27)
    Head and neck cancer 7 (23)
    Breast cancer 5 (17)
    Lymphoma/Myeloma 4 (13)
    Lung cancer 2 (7)
    Hepatobiliary tumor 2 (7)
    Other 2 (7)
Stage 
    I/II/III 6 (20)
    IV 24 (80)
Metastasis
    Present 18 (60)
    Absent 12 (40)
Current treatment
    Chemotherapy 29 (97)
    Palliative care 1 (3)
Duration of disease, median (range, mo) 9 (5-23)
Setting
    Inpatient 26 (87)
    Outpatient 4 (13)
Education 
    Less than high school 10 (33)
    High school or more 19 (63)
    Other 1 (3)
Table 2.  Internal consistency of each domain using Cronbach’s 
α coefficients
                             Cronbach’s α score
Characteristic Current  Polish
 pilot study version
Physical symptoms 0.812 0.68
Psychological issues 0.804 0.86
Religious and spiritual issues 0.589 0.65
Independence and activity 0.843 0.77
Family and social issues 0.754 0.80
Treatment issues 0.822 0.62
Table 3.  Correlation between the physical domain of the SPARC 
and FACT-G
                                              FACT-Physical         FACT-Social
 r p r p
K-SPARC-Physical 0.479 0.007
K-SPARC-Social   –0.130 0.493
FACT-G, Functional Assessment of Cancer Therapy-General;  
K-SPARC, Korean SPARC; SPARC, Sheffield Profile for Assess-
ment and Referral to Care.
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SPARC was assessed by Cronbach’s alpha coefficients with 
the following results: 0.812 for physical symptoms, 0.804 for 
psychological issues, 0.589 for religious and spiritual issues, 
0.843 for independence and activity, 0.754 for family and 
social issues, and 0.822 for treatment issues. Table 2 shows 
the comparison of the Cronbach’s α scores of the Korean and 
Polish versions of the SPARC. Table 3 shows the correlation 
between the physical and social domains of the SPARC and 
FACT-G. The correlation coefficient was significant at 0.479 
(p=0.007); however, the functional well-being domain of the 
FACT-G and the independence and activity domain of the 
SPARC (r=0.307, p=0.099) were not significantly correlated, 
and neither were the psychological domain of SPARC and 
the emotional well-being domain (r=0.175, p=0.356).  
Discussion
The SPARC is a holistic multidimensional screening inst-
rument for supportive and palliative care needs. It has also 
been used to capture the holistic needs of newly diagnosed 
lung cancer patients [16]. In this study, we developed a 
Korean translation of the SPARC and conducted a linguistic 
validation for cancer patients. The Korean version was first 
translated using the forward-back procedure. After the first 
version of the K-SPARC was created, it was back-translated 
into English and reviewed; minor variations from the origi-
nal English version were discussed and agreed for linguistic 
and cultural reasons and because of difference in healthcare 
systems. Subsequently, the validity and reliability of the 
K-SPARC (Supplementary Material) were assessed, and the 
tool was used with a sample of 30 patients with advanced 
cancer. During the pilot study, participants expressed an 
accurate understanding of the concepts.
In this pilot study, the internal consistency of the total 
scale and the subscales was assessed, with Cronbach’s alpha 
values for the subscales ranging from 0.589-0.843. The Cron-
bach’s alpha values of 5 of the subscales, including physical 
symptoms, psychological issues, independence and activity, 
treatment issues, and family and social issues, were over 0.75, 
and good or acceptable internal consistency was found when 
comparing the Korean and Polish versions. This finding 
indicates that the K-SPARC has high structural validity. How-
ever, although it was not unacceptable, the Cronbach’s alpha 
value of the religious and spiritual issues subscale was poor 
at 0.589. The religious and spiritual issues subscale compris-
es two questions with conflicting thoughts about death and 
dying and religious or spiritual needs not being met. In Korea, 
there are many obstacles and taboos regarding discussions of 
death, as in other Asian nations. There are differences among 
patients, family members, and physicians not only in terms 
of the disclosure of an incurable cancer diagnosis but also 
in terms of end-of-life discussion when death is imminent 
[17,18]. For example, a study used semistructured interviews 
to compare meaning-making in coping among cancer pati-
ents in Sweden and South Korea [19]. The study found that 
Korean patients hardly mentioned “spirituality” in the inter-
views, whereas cancer patients in Sweden were familiar with 
the construct of spirituality and used the term “spirituality” 
in their daily communication. This finding was attributed to 
Koreans’ difficulty in expressing issues related to spirituality 
in the Korean language rather than to Koreans’ intrinsic lack 
of spiritual consciousness. There is no consensus about the 
definition of spirituality among the general public in Korea, 
and spirituality can be defined in one’s own way. As a result, 
it is not unexpected that the Cronbach’s score would be poor 
for religious and spiritual issues, which included two ques-
tions about death and spirituality that Koreans are not used 
to discussing due to cultural obstacles to talking about death 
and unclear definitions of spirituality.
The correlations between the K-SPARC and FACT-G var-
ied. The K-SPARC was moderately correlated with the physi-
cal well-being domain of the FACT-G but weakly correlated 
with the social domain of the FACT. As mentioned above, 
this finding might be a result of cultural differences among 
nations. In addition, there were some differences between the 
FACT-G and K-SPARC in how social questions were asked. 
Questions from the social domain of the FACT-G focus on 
intimacy with and the care of family members or friends 
due to disease. However, the K-SPARC tends to focus on the 
impact of disease on family members and patient concerns. 
The low correlation between the K-SPARC and FACT-Social 
might be related to cultural differences between nations or 
the emphasis of questions, but this was difficult to conclude 
due to the small number of patients. An ongoing study is 
expected to clarify this issue. 
There are several limitations to our study. First, our sam-
ple was small (30 patients). Second, we did not evaluate test-
retest reliability. Finally, this study was a pilot study provid-
ing preliminary evidence of the validity of the K-SPARC. 
However, this study represents a fundamental step in the 
development of a Korean version of the SPARC, and future 
research to support further reliability and validity evidence 
is ongoing.
The present study developed K-SPARC and validated lin-
guistically. However, there are possible differences in culture 
or language use, and some problematic translations might 
be present. We are conducting another study to validate the 
psychometric properties of the K-SPARC, including the test-
retest reliability, convergent/divergent validity, and prog-
nostic value for Korean cancer patients.
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